Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: KEOCYT, Immeuble Cap Sud, 106 avenue Marx Dormoy, 92120 Montrouge, FRANCE
Zanosar 1 g, powder for concentrate for solution for infusion.
| Pharmaceutical Form |
|---|
|
Powder for concentrate for solution for infusion. Zanosar is a freeze-dried preparation available as a sterile, white to pale yellow powder. |
Each Zanosar vial contains 1 g of the active ingredient streptozocin.
The concentration of the reconstituted solution before dilution is 100 mg/mL.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Streptozocin |
|
| List of Excipients |
|---|
|
Citric acid anhydrous |
Powder in a 20 mL type I glass vial with a bromobutyl rubber stopper and sealed with an aluminium / plastic flip-off cap.
1 vial.
KEOCYT, Immeuble Cap Sud, 106 avenue Marx Dormoy, 92120 Montrouge, FRANCE
PL 40308/0001
03/04/2018
| Drug | Countries | |
|---|---|---|
| ZANOSAR | Estonia, Finland, Japan, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
